Robuta

https://www.globenewswire.com/news-release/2015/03/09/713500/10123752/en/Hemispherx-Enters-a-Collaboration-with-Emerge-Health-for-the-Commercialization-of-Ampligen-for-Chronic-Fatigue-Syndrome-CFS-in-Australia-and-New-Zealand.html
Hemispherx and Emerge Health to Commence Named Patient Sales While Seeking Formal Regulatory Approval...
emerge healthhemispherxenterscollaboration
https://www.biospace.com/hemispherx-biopharma-provides-corporate-update-on-various-strategic-initiatives
hemispherx biopharmacorporate updatestrategic initiativesprovidesvarious
https://www.biospace.com/hemispherx-biopharma-announces-the-completion-of-the-newly-upgraded-alferon-facility-commercial-production-of-alferon-is-in-the-final-stage-integrati
hemispherx biopharmaannouncescompletionnewlyupgraded
https://www.biospace.com/hemispherx-shakes-up-executive-management-team-after-terminating-longtime-ceo-last-week
executive management teamhemispherxshakesterminatinglongtime
https://www.globenewswire.com/news-release/2014/08/11/657601/29489/en/Hemispherx-Biopharma-Announces-Financial-Results-for-the-Six-Months-Ended-June-30-2014.html
Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations...
hemispherx biopharmafinancial resultsannounces